Cleared Traditional

K072515 - EMBRACE GEL

K072515 is an FDA 510(k) clearance for EMBRACE GEL, manufactured by Orison Corporation. The device is a Class 2 Radiology device with product code MUI cleared through the Traditional 510(k) pathway after a 13-day FDA review.

K072515 · Orison Corporation · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Sep 2007
Decision
13d
Days
Class 2
Risk

K072515 is an FDA 510(k) clearance for the EMBRACE GEL. Classified as Media, Coupling, Ultrasound (product code MUI), Class II - Special Controls.

Submitted by Orison Corporation (Johnson City, US). The FDA issued a Cleared decision on September 20, 2007 after a review of 13 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1570 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K072515

510(k) Number K072515 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 07, 2007
Decision Date September 20, 2007
Days to Decision 13 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d faster than avg
Panel avg: 107d · This submission: 13d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

MUI Device Classification - Class 2, Special Controls

Product Code MUI Media, Coupling, Ultrasound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Intertek Testing Services
DANIEL W LOHTONEN

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MUI Media, Coupling, Ultrasound

All 33
Devices cleared under the same product code (MUI) and FDA review panel - the closest regulatory comparables to K072515.
DYNAREX ULTRASOUND GEL
K102637 · Dynarex Corporation · Feb 2011
THE ADDITION
K102683 · Ob The-Addition, LLC · Jan 2011
LUBRICANO-ULTRASOUND
K083358 · Farco Pharma GmbH · Jan 2009
ULTRABIO - IN VIVO BIOCOMPATIBLE, BIOELIMINATED STERILE ULTRASOUND IMAGING COUPLANT
K042619 · Sonotech, Inc. · Nov 2004
ULTRABIO
K033178 · Sonotech, Inc. · Aug 2004
AUTOGEL PAD
K031018 · Rich-Mar Corp. · Dec 2003
K072515 · EMBRACE GEL
Download PDF FDA Summary Orison Corporation